Webinar

This webinar is a look into the future at how the risks of AL & ATTR amyloidosis will be managed and the diseases treated. An interesting perspective for patients, physicians and family members-plus the webinar includes 45 minutes of live Q & A with Dr. Comenzo.

Amyloidosis Support Groups webinar from May 21, 2022, covering the latest on light chain (AL) amyloidosis featuring ASG President Muriel Finkel and amyloidosis expert Melissa A. Lyle, MD, Cardiologist, Assistant Professor of Medicine, Cardiology Lead, Mayo Clinic Florida Multidisciplinary Amyloid Clinic, Jacksonville, FL, presents Amyloidosis and the Heart.

Amyloidosis Support Groups webinar for ATTR patients in the Pacific Northwest region recorded on March 13, 2021. Muriel Finkel, President of Amyloidosis Support Groups, leads the webinar which features top amyloidosis physicians in Oregon and Washington. The webinar is presented by: B. Jane Distad, MD, Director, EMG and Associate Professor, Department of Neurology, University of

Amyloidosis Support Groups webinar on ATTR amyloidosis from July 23, 2022. Led by ASG President Muriel Finkel, featured speaker Colleen Moffitt, PharmD, MS, US ATTR Medical Director, Alnylam Pharmaceuticals, talks about Alnylam Update.

ASG’s Northeastern regional webinar on ATTR amyloidosis, recorded on July 10, 2021. The webinar is presented by: Gabriela Tamariz, MD, Medical Science Liaison, TTR Program, Alnylam Pharmaceuticals

Amyloidosis Support Groups webinar from May 21, 2022, covering the latest on light chain (AL) amyloidosis featuring ASG President Muriel Finkel and amyloidosis expert Julia Catini, PharmD, Senior Medical Director, Amyloidosis, Alexion, Astra Zeneca Rare Disease, presents Alexion, Update on CAEL-101 Phase 2 and Phase 3 Studies.

ASG’s Northeastern regional webinar on ATTR amyloidosis, recorded on July 10, 2021. The webinar is presented by: Gabriela Tamariz, MD, Medical Science Liaison, TTR Program, Alnylam Pharmaceuticals.

Amyloidosis Support Groups webinar from May 21, 2022, covering the latest on light chain (AL) amyloidosis featuring ASG President Muriel Finkel and amyloidosis expert Julia Catini, PharmD, Senior Medical Director, Amyloidosis, Alexion, Astra Zeneca Rare Disease, presents Alexion, Update on CAEL-101 Phase 2 and Phase 3 Studies.

ASG’s Northeastern regional webinar on ATTR amyloidosis, recorded on July 10, 2021. The webinar is presented by: Gabriela Tamariz, MD, Medical Science Liaison, TTR Program, Alnylam Pharmaceuticals.

Amyloidosis Support Groups webinar from May 21, 2022, covering the latest on light chain (AL) amyloidosis featuring ASG President Muriel Finkel and amyloidosis expert Julia Catini, PharmD, Senior Medical Director, Amyloidosis, Alexion, Astra Zeneca Rare Disease, presents Alexion, Update on CAEL-101 Phase 2 and Phase 3 Studies.